Our featured companies! Top picks


Emerald Health Therapeutics, Inc.

CVE: EMH


Canadian symbol: EMH.V
US symbol: EMHTF

Currency in CAD

Valuation Measures

Market Cap (intraday) 545.11M
Enterprise Value 33.95M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)3.47
Price/Book (mrq)0.55
Enterprise Value/Revenue 30.30
Enterprise Value/EBITDA 6-0.14

Trading Information

Stock Price History

Beta (5Y Monthly) 0.89
52-Week Change 3-29.03%
S&P500 52-Week Change 317.60%
52 Week High 30.3100
52 Week Low 30.1200
50-Day Moving Average 30.2208
200-Day Moving Average 30.2080

Share Statistics

Avg Vol (3 month) 3390.41k
Avg Vol (10 day) 3392.81k
Shares Outstanding 5205.03M
Float 166.04M
% Held by Insiders 119.46%
% Held by Institutions 10.78%
Shares Short (Jan. 14, 2021) 4313.62k
Short Ratio (Jan. 14, 2021) 40.85
Short % of Float (Jan. 14, 2021) 4N/A
Short % of Shares Outstanding (Jan. 14, 2021) 40.15%
Shares Short (prior month Dec. 14, 2020) 4197.26k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:15
Last Split Date 3Sep. 08, 2014

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2019
Most Recent Quarter (mrq)Sep. 29, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-242.99%

Management Effectiveness

Return on Assets (ttm)-9.97%
Return on Equity (ttm)-91.66%

Income Statement

Revenue (ttm)13.02M
Revenue Per Share (ttm)0.07
Quarterly Revenue Growth (yoy)-63.70%
Gross Profit (ttm)-10.79M
EBITDA -27.46M
Net Income Avi to Common (ttm)-125.26M
Diluted EPS (ttm)-0.6960
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)68.67M
Total Cash Per Share (mrq)0.33
Total Debt (mrq)28.42M
Total Debt/Equity (mrq)35.45
Current Ratio (mrq)2.97
Book Value Per Share (mrq)0.40

Cash Flow Statement

Operating Cash Flow (ttm)-5.13M
Levered Free Cash Flow (ttm)-1.95M

mrq = Most Recent Quarter
ttm = Trailing Twelve Months
yoy = Year Over Year
lfy = Last Fiscal Year
fye = Fiscal Year Ending
fy = Forward Year
Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.

Fundamentals are updated every day.
Full screen




Cannabis Market and Business News

Real-time cannabis business news from hundreds of sources. Never miss the news that matters the most.




Company News Date
EMH.V
Emerald Health Therapeutics
4 weeks ago
EMH.V
Emerald Health Therapeutics
1 month ago
EMH.V
Emerald Health Therapeutics
3 months ago
EMH.V
Emerald Health Therapeutics
4 months ago
EMH.V
Emerald Health Therapeutics
4 months ago
EMH.V
Emerald Health Therapeutics
4 months ago
EMH.V
Emerald Health Therapeutics
4 months ago
EMH.V
Emerald Health Therapeutics
4 months ago
EMH.V
Emerald Health Therapeutics
4 months ago
EMH.V
Emerald Health Therapeutics
5 months ago
EMH.V
Emerald Health Therapeutics
5 months ago
EMH.V
Emerald Health Therapeutics
5 months ago
EMH.V
Emerald Health Therapeutics
5 months ago
EMH.V
Emerald Health Therapeutics
6 months ago
EMH.V
Emerald Health Therapeutics
7 months ago
EMH.V
Emerald Health Therapeutics
8 months ago
EMH.V
Emerald Health Therapeutics
8 months ago
EMH.V
Emerald Health Therapeutics
8 months ago
EMH.V
Emerald Health Therapeutics
10 months ago
EMH.V
Emerald Health Therapeutics
10 months ago
EMH.V
Emerald Health Therapeutics
10 months ago
EMH.V
Emerald Health Therapeutics
10 months ago
EMH.V
Emerald Health Therapeutics
10 months ago
EMH.V
Emerald Health Therapeutics
10 months ago
EMH.V
Emerald Health Therapeutics
10 months ago
EMH.V
Emerald Health Therapeutics
11 months ago
EMH.V
Emerald Health Therapeutics
12 months ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago
EMH.V
Emerald Health Therapeutics
1 year ago

Currency in CAD
Earnings EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
No. of Analysts0000
Avg. Estimate0000
Low Estimate0000
High Estimate0000
Year Ago EPSN/A-0.11N/AN/A
Revenue EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
No. of Analysts1011
Avg. Estimate4.27MN/A20.32M52.3M
Low Estimate11MN/A27.9M52.3M
High Estimate11MN/A27.9M52.3M
Year Ago Sales970kN/A1.95M20.32M
Sales Growth (year/est)340.40%N/A943.10%157.40%
Earnings HistoryInvalid Date2018-12-302019-06-292019-09-29
EPS Est.N/A0-0.06-0.05
EPS ActualN/A-0.110-0.12
DifferenceN/A-0.110.06-0.07
Surprise %N/AN/A100.00%-140.00%
EPS TrendCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
Current Estimate0000
7 Days Ago-0.050-0.2-0.21
30 Days Ago-0.050-0.2-0.21
60 Days Ago-0.050-0.2-0.21
90 Days Ago-0.050-0.2-0.21
EPS RevisionsCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesEMH.VIndustrySector(s)S&P 500
Current Qtr.N/AN/AN/AN/A
Next Qtr.N/AN/AN/AN/A
Current YearN/AN/AN/AN/A
Next YearN/AN/AN/AN/A
Next 5 Years (per annum)N/AN/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A


Insiders transactions are updated every hour.

Major Holders

Currency in CAD
Breakdown
19.46%% of Shares Held by All Insider
0.78%% of Shares Held by Institutions
0.96%% of Float Held by Institutions
4Number of Institutions Holding Shares

Top Institutional Holders

HolderSharesDate Reported% OutValue
AdvisorShares Investments, LLC1,597,751Sep. 29, 20200.77%295,583
Coming Soon

Search SEDAR Filings

Company Name:
Document Type:
Start Date:
End Date:

Press Releases by Emerald Health Therapeutics, Inc.


Emerald Health Therapeutics' Partner STENOCARE Makes First Delivery of Medical Cannabis Oil to Swedish Patients

Emerald Health Therapeutics’ Partner STENOCARE Makes First Delivery of Medical Cannabis Oil to Swedish Patients

Vancouver, British Columbia--(Newsfile Corp. - December 29, 2020) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald") today announced that its partner, STENOCARE A/S, completed its first shipment and delivery of Emerald medical cannabis oil to patients in Sweden.In Sweden, several patients diagnosed with chronic ner... Read More...
Emerald Health Therapeutics Introduces High Potency SYNC(TM) 100 CBD Oil

Emerald Health Therapeutics Introduces High Potency SYNC(TM) 100 CBD Oil

Vancouver, British Columbia--(Newsfile Corp. - December 17, 2020) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald") has launched and made its first shipment of its new SYNC™ 100 CBD oil to the province of Saskatchewan. Shipments to Alberta and BC are scheduled for next week, with product expected to be available f... Read More...
Emerald Health Therapeutics Terminates Agreement for Sale of Quebec Cannabis Business

Emerald Health Therapeutics Terminates Agreement for Sale of Quebec Cannabis Business

Vancouver, British Columbia--(Newsfile Corp. - December 4, 2020) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald") today announced that it has terminated its share purchase agreement dated July 30, 2020 (the "Agreement") with Quinto Resources Inc. ("Quinto") in respect of the proposed sale of Emerald's wholly-owne... Read More...
Emerald Health Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate Update

Emerald Health Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate Update

Emerald hosting conference call today, December 1st, at 10:30 am ETVancouver, British Columbia--(Newsfile Corp. - December 1, 2020) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald") has released its financial results for the three and nine months ended September 30, 2020. Full versions of Emerald's unaudited conde... Read More...
Emerald Health Therapeutics, Inc. to Host Earnings Call

Emerald Health Therapeutics, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / December 1, 2020 / Emerald Health Therapeutics, Inc. (OTCMKTS:EMHTF) will be discussing their earnings results in their 2020 Third Quarter Earnings call to be held on December 1, 2020 at 10:30 AM Eastern Time.To listen to the event live or access a replay of the call - visit https://www.investornetwork.com/even... Read More...
Emerald Health Therapeutics Announces Full Prepayment of Convertible Debentures

Emerald Health Therapeutics Announces Full Prepayment of Convertible Debentures

Emerald to report Q3 financial results on November 30th and host conference call on December 1st at 10:30 am ETVancouver, British Columbia--(Newsfile Corp. - November 24, 2020) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) (the "Company") has fully prepaid in cash all amounts owing under the convertible debentures issued ... Read More...
Emerald Health Therapeutics Completes Sale of Pure Sunfarms Interest & Achieves Pivotal Milestone in Transforming its Business

Emerald Health Therapeutics Completes Sale of Pure Sunfarms Interest & Achieves Pivotal Milestone in Transforming its Business

Vancouver, British Columbia--(Newsfile Corp. - November 2, 2020) -   Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) (the "Company") has completed the previously disclosed sale of its 41.3% interest in Pure Sunfarms Corp. ("PSF") to Village Farms International, Inc. ("Village Farms") (NASDAQ: VFF; TSX: VFF) for consideration ... Read More...
Emerald Health Therapeutics Launches Flavoured Cannabis Oils, Expanding SYNC(TM) Product Line

Emerald Health Therapeutics Launches Flavoured Cannabis Oils, Expanding SYNC(TM) Product Line

Combination of appealing natural flavourings and terpenes offers unique consumer experienceEmerald also launches new SYNC CBD nanoemulsion-based Fast Action Spray in BC and SaskatchewanVancouver, British Columbia--(Newsfile Corp. - October 19, 2020) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald") has expanded it... Read More...
Emerald Health Therapeutics Receives Standard Processing License for Richmond, BC Greenhouse Facility

Emerald Health Therapeutics Receives Standard Processing License for Richmond, BC Greenhouse Facility

Processing license permits Richmond site to process consumer products and vertically integrate into potential product segmentsVancouver, British Columbia--(Newsfile Corp. - October 13, 2020) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald") has received a newly issued Standard Processing License (the "Processing L... Read More...
Emerald Health Therapeutics Closes Shares for Debt Transaction

Emerald Health Therapeutics Closes Shares for Debt Transaction

Vancouver, British Columbia--(Newsfile Corp. - September 16, 2020) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) (the "Company") has closed its previously announced shares for debt financing. Further to its news release dated August 21, 2020, the Company has settled $625,000 of debt (the "Debt") payable to the holders (th... Read More...
Emerald Health Therapeutics and STENOCARE Receive Swedish Medicines Agency Approval to Provide Medical Cannabis Oil to Patients

Emerald Health Therapeutics and STENOCARE Receive Swedish Medicines Agency Approval to Provide Medical Cannabis Oil to Patients

Vancouver, British Columbia--(Newsfile Corp. - September 10, 2020) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald") and STENOCARE A/S today announced that they have received special approval from the Swedish Medicines Agency to provide medical cannabis oil to Swedish patients who have applied via their doctor to ... Read More...
Emerald Health Therapeutics Enters into Share Purchase Agreement for Sale of Pure Sunfarms

Emerald Health Therapeutics Enters into Share Purchase Agreement for Sale of Pure Sunfarms

Vancouver, British Columbia--(Newsfile Corp. - September 8, 2020) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) (the "Company") is pleased to announce that it has entered into a share purchase agreement (the "Share Purchase Agreement") with Village Farms International, Inc. (NASDAQ: VFF) (TSX: VFF) ("Village Farms") in re... Read More...
Emerald Health Therapeutics Reports Second Quarter 2020 Financial Results and Provides Corporate Update

Emerald Health Therapeutics Reports Second Quarter 2020 Financial Results and Provides Corporate Update

Vancouver, British Columbia--(Newsfile Corp. - September 1, 2020) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald") reported financial results for the three and six months ended June 30, 2020. Full versions of the Company's unaudited condensed interim consolidated financial statements and MD&A can be found on ... Read More...
Emerald Health Therapeutics Launches New Fast-Acting Cannabis Spray Products Offering Consumers Significantly Improved Predictability and Control of Effects

Emerald Health Therapeutics Launches New Fast-Acting Cannabis Spray Products Offering Consumers Significantly Improved Predictability and Control of Effects

SYNC(TM) Nano Fast Action Spray uses nanoemulsion technology to enable rapid onset and shorter duration of effects; the first THC product is in-market, with CBD to followVancouver, British Columbia--(Newsfile Corp. - August 31, 2020) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald") has launched the first product ... Read More...
Emerald Health Therapeutics' Pure Sunfarms Joint Venture Begins Shipping Cannabis 2.0 Products and Bottled Oils

Emerald Health Therapeutics’ Pure Sunfarms Joint Venture Begins Shipping Cannabis 2.0 Products and Bottled Oils

Pure Sunfarms' Full Spectrum Vapes in 510 thread cartridges and Pure Sun CBD Oil to be available to consumers in British Columbia in coming days; Ontario and Alberta to followEmerald will host its 2020 second quarter financial results conference call on Tuesday, September 1, 2020 at 10:30 AM ETVancouver, British Columbia--(Newsfile Corp. ... Read More...
Emerald Health Therapeutics Announces Shares for Debt Transaction

Emerald Health Therapeutics Announces Shares for Debt Transaction

Vancouver, British Columbia--(Newsfile Corp. - August 21, 2020) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) (the "Company") today announced that it has reached an agreement with the holders of convertible debentures of the Company issued on September 10, 2019 (the "Convertible Debentures") to settle accrued interest on ... Read More...
Emerald Health Therapeutics Announces New At-the-Market Equity Program

Emerald Health Therapeutics Announces New At-the-Market Equity Program

Vancouver, British Columbia--(Newsfile Corp. - August 13, 2020) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) (the "Company") today announced that it has established an at-the-market equity program ("ATM Program") that allows the Company to issue common shares from treasury ("Common Shares") having an aggregate gross sale... Read More...
Emerald Health Therapeutics and Quinto Resources Enter into Share Purchase Agreement for Sale of Quebec Cannabis Business

Emerald Health Therapeutics and Quinto Resources Enter into Share Purchase Agreement for Sale of Quebec Cannabis Business

Vancouver, British Columbia--(Newsfile Corp. - July 31, 2020) - Emerald Health Therapeutics, Inc. (TSXV: EMH) ("Emerald") and Quinto Resources Inc. ("Quinto") (TSXV: QIT) today announced that they have entered into a share purchase agreement dated July 30, 2020 (the "Agreement") in respect of the sale of Emerald's wholly-owned subsidiarie... Read More...
Emerald Health Therapeutics' Pure Sunfarms Joint Venture Begins Shipping Branded Products to Manitoba

Emerald Health Therapeutics’ Pure Sunfarms Joint Venture Begins Shipping Branded Products to Manitoba

Pure Sunfarms remains top-selling dried cannabis brand with Ontario Cannabis Store1 and achieves sales records in JulyVANCOUVER, July 24, 2020 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) today announced that its joint venture for large-scale, low-cost, high-quality cannabis production, Pure Sunfarms, has beg... Read More...
Emerald Health Therapeutics Terminates Consulting and Loan Agreements

Emerald Health Therapeutics Terminates Consulting and Loan Agreements

VANCOUVER, July 15, 2020 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) has terminated certain related party agreements pertaining to consulting services and a loan facility.Emerald Health Sciences Inc. ("EHS"), a control person of Emerald, and Emerald entered into an independent contractor agreement on May 1, ... Read More...
Emerald Health Therapeutics Announces Completion of Accordion Provision of Pure Sunfarms' Credit Facility

Emerald Health Therapeutics Announces Completion of Accordion Provision of Pure Sunfarms’ Credit Facility

VANCOUVER, British Columbia, July 01, 2020 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) today announced that its joint venture for large-scale, low-cost, high-quality cannabis production, Pure Sunfarms, has further expanded its credit facility (the “Credit Facility”) with the lending syndicate led by Bank of ... Read More...
Emerald Health Therapeutics' Joint Venture Pure Sunfarms' Branded Products Ship to Saskatchewan and are Approved in Manitoba

Emerald Health Therapeutics’ Joint Venture Pure Sunfarms’ Branded Products Ship to Saskatchewan and are Approved in Manitoba

VANCOUVER, British Columbia, June 24, 2020 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) today announced that its joint venture for large-scale, low-cost, high-quality cannabis production, Pure Sunfarms, has begun shipping branded, packaged dried flower products to Saskatchewan following approval from the Sask... Read More...
Emerald Health Therapeutics' Verdélite Launches Souvenir™ Cannabis Brand in Québec

Emerald Health Therapeutics’ VerdĂ©lite Launches Souvenir™ Cannabis Brand in QuĂ©bec

VANCOUVER, British Columbia, June 23, 2020 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) announces that its Verdélite Sciences subsidiary in St. Eustache, Québec, has launched its new Souvenir cannabis brand in the province. The Souvenir product line initially consists of select dried flower products from two ... Read More...
Emerald Health Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update

Emerald Health Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update

VANCOUVER, British Columbia, June 19, 2020 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) reported financial results for the quarter and ended March 31, 2020. Full versions of the Company’s unaudited condensed interim consolidated financial statements and MD&A can be found on SEDAR at www.sedar.com.“In the ... Read More...
Emerald Health Therapeutics to Host 2020 First Quarter Financial Results Conference Call on Friday, June 19, 2020 at 10:30 AM ET

Emerald Health Therapeutics to Host 2020 First Quarter Financial Results Conference Call on Friday, June 19, 2020 at 10:30 AM ET

VANCOUVER, British Columbia, June 11, 2020 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) today announced that, further to its news release on April 29th, Emerald will report its financial results for the first quarter ended March 31, 2020, after the market close on Thursday, June 18, 2020. The company will hos... Read More...
Emerald Health Therapeutics Closes $2.1 Million Prospectus Sale

Emerald Health Therapeutics Closes $2.1 Million Prospectus Sale

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATESVANCOUVER, British Columbia, June 02, 2020 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF), is pleased to announce that it has closed its prospectus offering (the "Offering") to certain institutional accredited investors (the... Read More...
Emerald Health Therapeutics Terminates Land Sub-lease and Outdoor Cultivation Agreements

Emerald Health Therapeutics Terminates Land Sub-lease and Outdoor Cultivation Agreements

VANCOUVER, British Columbia, May 27, 2020 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) announces that it has terminated certain related party agreements pertaining to its cannabis cultivation operation in Metro Vancouver. Previously existing rights and continuing usage of the land and its cultivation operatio... Read More...
Emerald Health Therapeutics Announces Pure Sunfarms' Initial Cultivation and Sales License for Second Greenhouse

Emerald Health Therapeutics Announces Pure Sunfarms’ Initial Cultivation and Sales License for Second Greenhouse

VANCOUVER, British Columbia, May 25, 2020 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) announces that its joint venture for large-scale, low-cost, high-quality cannabis production, Pure Sunfarms, has received from Health Canada its cannabis cultivation and sales licence based on an initial production area wit... Read More...
Emerald Announces $2.1 Million Prospectus Sale

Emerald Announces $2.1 Million Prospectus Sale

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATESVANCOUVER, British Columbia, May 21, 2020 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF), has entered into a binding term sheet with a single Canadian institutional accredited investor (the “Investor”) under which the Invest... Read More...
Emerald Health Therapeutics Reports Pure Sunfarms First Quarter 2020 Financial Results

Emerald Health Therapeutics Reports Pure Sunfarms First Quarter 2020 Financial Results

Pure Sunfarms achieves fifth consecutive profitable quarter and 179% quarter-to-quarter growth in retail branded product sales volume; builds on retail success in Ontario with 20% market share in April; continues leadership in low-cost cultivationVANCOUVER, British Columbia, May 15, 2020 -- Emerald Health Therapeutics, Inc. (“Emerald”) (T... Read More...
Emerald Health Therapeutics Reports Year-end and Fourth Quarter 2019 Financial Results and Provides Corporate Update

Emerald Health Therapeutics Reports Year-end and Fourth Quarter 2019 Financial Results and Provides Corporate Update

VANCOUVER, British Columbia, May 14, 2020 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) reported financial results for the quarter and year ended December 31, 2019. Full versions of the Company’s audited consolidated financial statements and MD&A can be found on SEDAR at www.sedar.com.“In the second half o... Read More...
Emerald Health Therapeutics to Host 2019 Fourth Quarter and Year End Financial Results Conference Call on Thursday, May 14, 2020 at 10:30 AM ET

Emerald Health Therapeutics to Host 2019 Fourth Quarter and Year End Financial Results Conference Call on Thursday, May 14, 2020 at 10:30 AM ET

VANCOUVER, May 08, 2020 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) today announced that, further to its news release on April 29th, Emerald will report audited financial results for the fourth quarter and year ended December 31, 2019 after the market close on Wednesday, May 13, 2020. The company will host a... Read More...
Emerald Health Therapeutics Extends Dates for Filing Financial Statements

Emerald Health Therapeutics Extends Dates for Filing Financial Statements

VANCOUVER, April 29, 2020 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) announces that as a result of the COVID-19 pandemic, Emerald, as well as its auditors and filing agents, have followed the recommendations of local health authorities and temporarily closed their offices, having employees work remotely to ... Read More...
Emerald Health Therapeutics to Launch Rapid Onset Nanoemulsion Cannabinoid & Terpene Product Line, Providing Consumers with Enhanced Immediacy and Control

Emerald Health Therapeutics to Launch Rapid Onset Nanoemulsion Cannabinoid & Terpene Product Line, Providing Consumers with Enhanced Immediacy and Control

Unique product line uses advanced technology to improve cannabinoid absorption by roughly 65% to provide more predictable dosing, onset and effects, as well as discreetness and value, of THC and CBD products for medicinal and adult-use usersVANCOUVER, April 29, 2020 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF... Read More...
Emerald Health Therapeutics Proposes to Amend Warrant Terms

Emerald Health Therapeutics Proposes to Amend Warrant Terms

VANCOUVER, British Columbia, April 06, 2020 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) announces that it intends to amend the terms of certain common share purchase warrants originally issued on September 9, 2019 (the “Warrants”).An aggregate of 12,500,000 Warrants were initially issued at an exercise price... Read More...
Emerald Health Therapeutics Releases First Harvest of Premium Cannabis from its 100%-Owned Cultivation Facility in Richmond, BC

Emerald Health Therapeutics Releases First Harvest of Premium Cannabis from its 100%-Owned Cultivation Facility in Richmond, BC

Purpose-built facility for organic cannabis production adds to Emerald’s ability to grow and sell its own unique premium-quality cannabis productsTwo wholly-owned operations in full production position Emerald for financial growth and sustainabilityVANCOUVER, British Columbia, April 06, 2020 -- Emerald Health Therapeutics, Inc. (“Emerald”... Read More...
Emerald Health Therapeutics' Pure Sunfarms JV Expands Credit Facility with Existing Lender by up to $59M and Completes Additional $8M Financing

Emerald Health Therapeutics’ Pure Sunfarms JV Expands Credit Facility with Existing Lender by up to $59M and Completes Additional $8M Financing

VANCOUVER, British Columbia, April 03, 2020 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) announced that its Pure Sunfarms (“PSF”) joint venture has finalized the expansion of its credit facility with its existing lender to $59 million, including accordion provisions of $22.5 million. The expanded credit facil... Read More...
Emerald Health Therapeutics' Pure Sunfarms JV Expands Credit Facility with Existing Lender by up to $59M

Emerald Health Therapeutics’ Pure Sunfarms JV Expands Credit Facility with Existing Lender by up to $59M

VANCOUVER, BC / ACCESSWIRE / March 31, 2020 / Emerald Health Therapeutics, Inc. ("Emerald") (TSXV:EMH; OTCQX:EMHTF) announced that its Pure Sunfarms ("PSF") joint venture has expanded its credit facility with its existing lender to $59 million, including accordion provisions of $22.5 million. The expanded credit facility (the "Credit Faci... Read More...
Emerald Health Therapeutics' Joint Venture, Pure Sunfarms, Reports Positive Operating and Financial Growth in 2019, with Significant EBITDA Performance of $54.1 Million

Emerald Health Therapeutics’ Joint Venture, Pure Sunfarms, Reports Positive Operating and Financial Growth in 2019, with Significant EBITDA Performance of $54.1 Million

VANCOUVER, BC / ACCESSWIRE / March 31, 2020 / Emerald Health Therapeutics, Inc. ("Emerald") (TSXV:EMH; OTCQX:EMHTF) has provided audited financial results for the fourth quarter and year of 2019 for its British Columbia-based joint venture, Pure Sunfarms (PSF).Financial DataAll comparable figures are for the year and quarter ended Decembe... Read More...
Emerald Health Therapeutics' Pure Sunfarms JV Receives Health Canada Approval for State-of-the-Art Processing Centre

Emerald Health Therapeutics’ Pure Sunfarms JV Receives Health Canada Approval for State-of-the-Art Processing Centre

Expanded processing facility enables further optimization of operations and quality processes Pure Sunfarms also increases market share in Ontario in first months of 2020 and launches new larger-format packageVANCOUVER, BC / ACCESSWIRE / March 23, 2020 / Emerald Health Therapeutics, Inc. ("Emerald") (EMH.V)(EMHTF) announced that its Pure ... Read More...
Emerald Health Therapeutics Signs LOI with Sigma Analytical Services

Emerald Health Therapeutics Signs LOI with Sigma Analytical Services

VANCOUVER, British Columbia, March 09, 2020 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) (“Emerald”) has signed a letter of intent under which Sigma Analytical Services Inc. (“Sigma”), a full-service GMP-compliant testing laboratory for cannabis, hemp, and derived products, may acquire Emerald’s Avalite canna... Read More...
Emerald Health Therapeutics, Pure Sunfarms, and Village Farms Complete Settlement of All Disputes

Emerald Health Therapeutics, Pure Sunfarms, and Village Farms Complete Settlement of All Disputes

VANCOUVER, British Columbia, March 09, 2020 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) today announced that, further to its news release dated March 3, 2020, all transactions contemplated by the settlement agreement (the "Settlement Agreement") among Emerald, Village Farms International, Inc. ("Village Farm... Read More...
Emerald Health Therapeutics, Pure Sunfarms, and Village Farms Settle All Disputes

Emerald Health Therapeutics, Pure Sunfarms, and Village Farms Settle All Disputes

VANCOUVER, British Columbia, March 03, 2020 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) has entered into a settlement agreement (the "Settlement Agreement") with Village Farms International, Inc. ("Village Farms") and Pure Sunfarms Corp. ("PSF," and together with Emerald and Village Farms, the "Parties") reg... Read More...
Emerald Health Therapeutics' Pure Sunfarms Joint Venture Makes First Cannabis Shipment to Alberta

Emerald Health Therapeutics’ Pure Sunfarms Joint Venture Makes First Cannabis Shipment to Alberta

VANCOUVER, British Columbia, Feb. 26, 2020 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) announced that its 50%-owned joint venture for large-scale, low-cost, quality cannabis production, Pure Sunfarms Corp. (“Pure Sunfarms” or “PSF”), has completed its first shipment of cannabis under its supply agreement wit... Read More...
Emerald Health Therapeutics Closes Final Tranche Prospectus Sale

Emerald Health Therapeutics Closes Final Tranche Prospectus Sale

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATESVANCOUVER, British Columbia, Feb. 14, 2020 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) has closed the final tranche of its $3,000,000 prospectus offering (the “Offering”), announced in its news release dated January 6, 20... Read More...
Emerald Health Therapeutics Closes $2.2 Million Prospectus Sale

Emerald Health Therapeutics Closes $2.2 Million Prospectus Sale

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATESVANCOUVER, British Columbia, Feb. 06, 2020 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) has closed the first tranche of its $3,000,000 prospectus offering (the “Offering”) announced in its news release dated January 6, 202... Read More...
Emerald Health Therapeutics Closes Shares for Debt Financing

Emerald Health Therapeutics Closes Shares for Debt Financing

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATESVANCOUVER, British Columbia, Jan. 31, 2020 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF), is pleased to announce that it has closed its previously announced shares for debt financing. Further to its news release dated Janua... Read More...
Emerald Health Therapeutics Provides Update on Financing Transactions

Emerald Health Therapeutics Provides Update on Financing Transactions

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATESVANCOUVER, British Columbia, Jan. 27, 2020 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) today provided an update on a previously announced shares for debt transaction. Further to its news release dated December 16, 2019, E... Read More...
Coming Soon.

Delayed data (1h)


Share this page